baber/WOPTO huggingface dataset:
Patent AU-3946193-A (AU)
Title: Near-end communications line characteristic measuring system
Inventor: ROSS ALAN
IPC: H04B3/46
Filed: 1993-01-21
Abstract: A method and apparatus (3, 60, 202, 300) for measuring the dynamic, or alternating current, and static, or direct current, characteristics of a cable pair (2, 10, 24, 133) from one end, the local end, by utilizing an element (1, 19, 20) possessing known non-linear electrical characteristics connected across the other end, the remote end, together with methods and apparatus (30, 111) for connecting the non-linear element (1) across the remote end of the cable pair (2, 10, 24, 133) and disconnecting the non-linear element 11) by means of electrical voltages impressed across the cable pair (2, 10, 24, 133) at the local end. In the method and system of the present invention, the near end test set (3, 60, 202, 300) is electrically transposed to the far end of the cable pair (2, 10, 24, 133) making it appear, to be at the far end during the test while, physically remaining at the near end. The non-linear element (1), in its non-linear region, when suitably excited by two or more alternating signals of different frequencies ( 4, 12, 13, 41, 42, 113, 114), produces additional frequencies which travel back from the far end to the near end of the cable pair (2, 10, 24, 133) and are modified by the characteristics of the cable pair (2, 10, 24, 133). By selecting specific excitation frequencies and measuring the characteristics of the additional frequencies returned (6, 22, 52, 200), the characteristics of the cable (2, 10, 24, 133) can be deduced.
Patent AU-3973995-A (AU)
Title: Direct current arc furnace
Inventor: AIGNER BERNHARD DIPL ING
IPC: F27D99/00
Filed: 1995-11-30
Abstract: PCT No. PCT/AT95/00236 Sec. 371 Date Jun. 2, 1997 Sec. 102(e) Date Jun. 2, 1997 PCT Filed Nov. 30, 1995 PCT Pub. No. WO96/17091 PCT Pub. Date Jun. 6, 1996A d.c. arc furnace for metallurgical purposes includes two or more electrodes arranged on the furnace vessel and projecting into the furnace vessel. To avoid actions of forces departing from the magnetic fields derived form the currents conducted to the electrodes and effecting deflections of the electric arcs, the electric supply means provided for each of the electrodes are each arranged in the immediate vicinity of the electrode to be supplied, the electric supply means of one electrode being arranged so as to be spacially separated from the electric supply means of the remaining electrodes, viewed in the peripheral direction of the furnace vessel.
Patent AU-4237893-A (AU)
Title: Process and apparatus for making photovoltaic devices and resultant product
Inventor: FOOTE JAMES B
IPC: H01L31/073
Filed: 1993-05-06
Abstract: A method for making a large area photovoltaic device (22) that is capable of generating low cost electrical power. The method involves depositing a layer of cadmium telluride onto an upwardly facing surface of a substrate and depositing an additional semiconductor material as a separate layer. The semiconductor interfaces the cadmium telluride such that an electrical junction can be formed.
Patent AU-4419896-A (AU)
Title: 4-{(heterocycloalkyl or heteroaromatic)-substituted phenyphenyl}-2-azetidinones useful as hypolipidemic agents
Inventor: VACCARO WAYNE D
IPC: C07D401/10
Filed: 1995-12-18
Abstract: 4-[(Heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinone hypocholesterolemic agents of the formula    <IMAGE>  I  or a pharmaceutically acceptable salt thereof, wherein: A is optionally substituted heterocycloalkyl, heteroaryl, benzofused heterocycloalkyl, or benzofused heteroaryl; Ar1 and Ar2 are optionally substituted aryl; Q is a bond or, with the 3-position ring carbon of the azetidinone, forms a spiro group; and R1 is alkylene; alkylene wherein a carbon in the chain is replaced by -O-, -C(O)-, phenylene, -NR8-, -S(O)0-2- or cycloalkylene; or alkenylene; or, when Q is a bond, R1 can be alkylene substituted by one or two hydroxy groups or hydroxy derivatives, wherein the alkylene chain can optionally be joined to Ar1 through -O- or -S(O)0-2- or joined to the azetidinone ring through a -S(O)0-2- group; a method of lowering serum cholesterol by administering said compounds, pharmaceutical compositions containing them, and the combination of a substituted azetidinone and a cholesterol biosynthesis inhibitor for the treatment and prevention of atherosclerosis.
Patent AU-4475285-A (AU)
Title: Immunoassay for detection of common determinant antibody to hepatitis B
Inventor: DECKER RICHARD H
IPC: G01N33/543
Filed: 1985-07-10
Abstract: The invention relates to immunoassays for the detection of a common antigenic determinant of hepatitis B virus. More particularly, the invention relates to immunoassays for detecting antibody to hepatitis B surface antigen/a.
Patent AU-4589000-A (AU)
Title: Polynucleotides
Inventor: GOLDSBOROUGH ANDREW SIMON
IPC: C12Q1/68
Filed: 2000-05-02
Abstract: Provided is a preparative method for isolating RNA comprising an oligo-or polynucleotide from a sample, which method comprises: (a) treating the sample with a reactant capable of covalently modifying the 2'-OH position of the ribose rings of the RNA under conditions so that a proportion of the 2'-OH positions of the ribose rings bear a substituent; and (b) preparing isolated RNA therefrom by separating material containing the substituent from the sample on the basis of a property of the substituent.
Patent AU-4589293-A (AU)
Title: Composition for controlled release of an active substance and method for the preparation of such a composition
Inventor: BESEMER ARIE CORNELIS
IPC: A61K9/22
Filed: 1993-07-02
Abstract: PCT No. PCT/NL93/00138 Sec. 371 Date Feb. 15, 1995 Sec. 102(e) Date Feb. 15, 1995 PCT Filed Jul. 2, 1993 PCT Pub. No. WO94/01091 PCT Pub. Date Jan. 20, 1994In a composition for delayed release of an active substance, the active substance is incorporated in a polysaccharide matrix which consists of an essentially crystalline straight-chain glucan and contains a glucan-degrading agent. The glucan is in particular an  alpha -glucan which has essentially a helix structure. The glucan-degrading agent is preferably  alpha -amylase. The composition can contain high-molecular materials such as proteins, allergens, vaccine substances and microorganisms, and preferably has the form of compressed tablets.
Patent AU-4807990-A (AU)
Title: Antinephrotoxic perfusion solution
Inventor: BERTERMANN HAGEN
IPC: A61P13/02
Filed: 1989-12-21
Abstract: Use of a mixture of various L-amino acids to protect the kidneys from toxic damage due to cytostatic and immunosuppressive drugs.
Patent AU-4837697-A (AU)
Title: Process and plant for producing porous ammonium nitrate
Inventor: VOGEL EDMOND
IPC: B01J2/16
Filed: 1997-12-16
Abstract: A process is claimed for the manufacture of porous ammonium nitrate granules using a rotary drum granulator with a fluidised bed. Caps of solid ammonium nitrate are introduced and a solution of 94 - 98% ammonium nitrate is sprayed at 135 - 170 degrees C. Part of the water in the course of granulation is removed by the heat of crystallisation of the nitrate and an airflow blown under the bed.The remaining water is eliminated in a drying operation after granulation. Also claimed is the installation for the process.
Patent AU-4987690-A (AU)
Title: Hydroxyalkane carboxylic acid derivatives, their production and use
IPC: C07D265/30
Filed: 1990-02-16
Abstract: The invention relates to hydroxycarboxylic acid derivatives of the general formula I <IMAGE>  in which   R1 represents a hydrogen atom or an acyl group having not more than 16 carbon atoms, R2 and R3 denote in each case alkyl groups having not more than 8 carbon atoms or together denote an alkylene group having 4 to 8 carbon atoms which is optionally interrupted by an oxygen atom or a nitrogen atom and n stands for the numbers 7 to 18, with the proviso that it does not denote the number 10 if R2 and R3 in each case denote an ethyl group or in each case denote a n-butyl group and that it does not denote the number 15 if R2 and R3 in each case represent a methyl group.
Patent AU-5072300-A (AU)
Title: Cross frog
Inventor: BENENOWSKI SEBASTIAN
IPC: E01B7/10
Filed: 2000-05-26
Abstract: The invention relates to a cross frog (10) for points and crossings, comprising a cross frog tip (14) and wing rails (16, 18) and running rails (20, 22) situated either side of this point, each with a basic course (38) aligned with a main or secondary track (26, 28). The aim of the invention is to reduce the wear around the cross frog tip without reconstructing the cross frog tip itself or the guard rails allocated thereto or realigning them in relation to each other. To this end, at least one of the running rails deviates from its basic course in the area of the cross frog tip, in such a way that the movement of a rail vehicle running through the main or secondary track is influenced through its wheel frame or bogie axle, away from the cross frog tip.
Patent AU-5187999-A (AU)
Title: Human neuronal acid-sensitive cationic channels, its cloning and applications
Inventor: WALDMANN RAINER
IPC: C12N15/12
Filed: 1999-08-05
Abstract: Non inactivating or slowly inactivating proton-gated cation channels are thought to play an important role in the perception of pain that accompanies tissue acidosis. We have identified a novel human proton-gated cation channel subunit that has biphasic desensitisation kinetics with both a rapidly inactivating Na+-selective and a sustained component. The protein shares 84% sequence identity with the proton-gated cation channel rASIC3 (rDRASIC) from rat sensory neurones. The biphasic desensitisation kinetics and the sequence homology suggest that this novel clone (hASIC3) is the human orthologue of rASIC3 (rDRASIC). While rASIC3 (rDRASIC) requires very acidic pH (<pH 4.5) for activation of the sustained current, the non-inactivating hASIC3 current starts to be activated when the pH decreases to below pH 6. hASIC3 is ant acid sensor and might play an important role in the detection of lasting pH changes in human. We localized the hASIC3 gene to the human chromosome 7q35, 6.4 cRad telomeric from the microsatellite AFMA082XC9.
Patent AU-5221898-A (AU)
Title: Display cassette for an interchangeable information carrier with a carrier housing which can be closed by at least one hinged lid
Inventor: WESTERMANN GERHARD
IPC: G09F3/20
Filed: 1997-10-23
Abstract: In an information cassette for receiving exchangeable information carriers including a carrier housing, the carrier housing has bent over top and bottom end walls and a T-shaped center web so as to form two information carrier sections covered by hinge lids on which the information carriers can be mounted and which have bottom walls with springs on which the hinge lids are seated in the carrier housing and which resiliently bias the hinge lids upwardly such that the top ends of the hinge lids are engaged behind the front edges of the bent-over carrier housing top end wall or the T-shaped center web, respectively.
Patent AU-5301800-A (AU)
Title: Swimming pool pressure cleaner with internal steering mechanism
Inventor: RIEF DIETER J
IPC: E04H4/16
Filed: 2000-05-26
Abstract: A swimming pool pressure cleaner (20) of the type motivated by water flow through it having: a set of two wheels (22a, b) rotatably mounted to the body (24); a turbine housing (38) having a water-flow chamber (40) with an inlet (70) and an outlet (74), the inlet held in proximity to the pool surface (54); a vaned rotor (48) rotatably mounted in the chamber; one or more one venturi jets (66a, b) secured to the body and oriented to direct water into the inlet to rotate the turbine and cause flow from the pool into the inlet; a drive member (76) secured to the rotor and a drive train extending to the wheels for synchronous rotation on the pool surface; a cam (100) rotatably secured to the body and drive by the rotor through reduction gearing (106); and a linkage (94) from the cam to one wheel (22a) to periodically interrupt the synchronous rotation of the wheels on the pool surface and change pool cleaner direction.
Patent AU-5357299-A (AU)
Title: Yeast transformation cassette
Inventor: BAUER JUERGEN
IPC: C12N15/81
Filed: 1999-10-08
Abstract: A DNA cassette (I) for the transformation of yeast not including any exogenous DNA other than the gene of interest is new and comprises at least: (a) a dominant negative marker; (b) two non-exogenous and non-recombinant, directly repeated sequences (DRS) with the genome of the host strain; (c) eventually at least a gene of interest, with the necessary elements for expression in the host cell. A DNA cassette (I) for the transformation of yeast not including any exogenous DNA other than the gene of interest is new and comprises at least: (a) a dominant negative marker; (b) two non-exogenous and non-recombinant, directly repeated sequences (DRS) with the genome of the host strain, the two sequences are positioned in either part of the fragment and contain the dominant positive marker; (c) eventually at least a gene of interest, with the necessary elements for expression in the host cell. Independent claims are also included for the following: (1) a process (II) for the integration of a target gene or the inactivation of a gene in the yeast comprising: (a) transforming the yeast with the help of a DNA construct comprising (I); (b) selecting the yeast comprising the integrated cassette using the positive marker; (c) then, after culture, the yeast is selected comprising the cassettes that has been excised using DRS in selecting yeast deprived of the negative marker; (2) a process for the transformation of an auxotrophic yeast with a plasmid shuttle to obtain expression of an elevated number of copies of at least a gene of interest comprising: (i) transforming the yeast with a plasmid shuttle; (ii) selecting on minimal medium allowing for the induction of the negative marker, the cells not comprising the plasmids in which the part corresponding to Escherichia coli fragments and to the negative marker has been excised; and (3) yeast transformed using (I) obtained by (II) and only contain the DNA of the yeast with the eventual exception of some of the gene(s) coding for a protein of interest and non-coding DRS sequences.
Patent AU-5418194-A (AU)
Title: Novel vitamin d analogues
Inventor: CALVERLEY MARTIN JOHN
IPC: A61P5/12
Filed: 1993-11-01
Abstract: PCT No. PCT/DK93/00351 Sec. 371 Date May 2, 1995 Sec. 102(e) Date May 2, 1995 PCT Filed Nov. 1, 1993 PCT Pub. No. WO94/10139 PCT Pub. Date May 11, 1994The invention relates to 20(S)-vitamin D compounds having the following formula   <IMAGE>   where U and R' are as defined in the specification. The compounds have strong antiinflammatory and immunomodulating activity. There are also useful in the inhibition of proliferation of undesirable cells.
Patent AU-5448000-A (AU)
Title: Diagnostics and therapeutics for cardiovascular disorders
Inventor: FRANCIS SHEILA E
IPC: C12Q1/68
Filed: 2000-05-26
Abstract: The kits and methods of the present invention relate to the diagnosis of cardiovascular disorders.
Patent AU-5640098-A (AU)
Title: Compositions for drying solid surfaces
Inventor: MICHAUD PASCAL
IPC: C09K3/18
Filed: 1998-03-02
Abstract: A dewatering composition comprises a solution of a surfactant in a mixture of a fluorinated solvent and a polyfluorinated alcohol of formula (I): Rf-(CH2)n-OH (I) n = 1 or 2; and Rf = 4 - 8C perfluoroalkyl radical.
Patent AU-5665099-A (AU)
Title: Methods and apparatus for providing robust synchronization of radio transceivers
Inventor: MATTISSON SVEN
IPC: H04L7/04
Filed: 1999-08-17
Abstract: Methods and apparatus for performing synchronization and DC-offset compensation in FM transmission systems significantly reduce the overhead associated with transmitting a conventional digital preamble at the start of each of a succession of transmitted digital data packets. According to exemplary embodiments, a multi-part digital preamble includes a short, substantially DC-free leading part followed by a code-protected synchronization part which is not necessarily substantially DC-free. The leading part provides for coarse DC offset estimation and synchronization, while the coded synchronization part carries timing and/or other useful information which can be unique for each packet. One or more substantially DC-free trailing parts follow the synchronization part, or are included in the synchronization part itself, and provide for fine tuning of the DC-offset estimate. Since the substantially DC-free leading and trailing parts are extremely short, and since the synchronization part carries useful information, the overhead associated with a preamble according to the invention is significantly reduced as compared to a conventional, entirely DC-free, preamble.
Patent AU-5744699-A (AU)
Title: Call control in intelligent networks
Inventor: WALLENIUS JUKKA
IPC: H04W4/20
Filed: 1999-09-02
Abstract: The presentation of information identifying a calling user of a terminal device (MS-A) to a called terminal device (MS-B) in a communication involving a radio access network is triggered upon receipt of an incoming call; if triggered, the information is presented to a user at a man machine interface (MMI) of the terminal device; a user input is collected via the man machine interface (MMI) in response to the presentation, and the received call is controlled according to the collected user input. It becomes advantageously possible to initiate a retrieval procedure for calling party identifying information while the call is being controlled by a service control device and prior to the routing of the call to the called terminal device.
Patent AU-5783300-A (AU)
Title: Anilinoquinazolines as protein tyrosine kinase inhibitors
Inventor: COCKERILL GEORGE STUART
IPC: B60J11/00
Filed: 2000-06-30
Abstract: Heteroaromatic compounds are described, methods for their preparation, pharmaceutical compositions containing them, methods of use, and their use in medicines. In particular, the invention relates to quinazoline and pyridopyrimidine derivatives which exhibit protein tyrosine kinase inhibition.
Patent AU-5795594-A (AU)
Title: New N-benzylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
Inventor: WIERZBICKI MICHEL
IPC: C07D295/088
Filed: 1994-03-22
Abstract: The N-benzylpiperazine compounds of formula: <IMAGE>  in which R is as defined in the description. These new compounds and their physiologically tolerable acid addition salts can be used in therapeutics.
Patent AU-5972198-A (AU)
Title: Method and apparatus for controlling flow of casing glass in a cased glass stream
Inventor: SCOTT GARRETT L
IPC: C03B3/00
Filed: 1998-03-30
Abstract: Apparatus (10) for forming a cased glass stream having an inner core glass surrounded by an outer casing glass includes a first orifice (24) for receiving core glass from a first source (12). A second orifice (26) is vertically spaced beneath and aligned with the first orifice, and is surrounded by a chamber (30) that communicates with the second orifice through a gap between the first and second orifices. A spout (36) delivers casing glass from a second source (40) through a tube (32) to the chamber in such a way that glass flows by gravity from the first and second sources through the orifices to form the cased glass stream. Rate of glass flow through the second or casing glass source (40) is measured and compared with one or more preset limits (78). Rate of casing glass flow from the second source to the chamber surrounding the orifices is adjusted when rate of flow through the second source departs from the preset limit. In this way, a desired ratio of casing glass to core glass, and consequently the desired thickness of the casing glass layer, is automatically maintained.
Patent AU-6161300-A (AU)
Title: Rolling stand
Inventor: BERGER BERND
IPC: B21B13/14
Filed: 2000-08-01
Abstract: The invention relates to a roll stand comprising a pair of work rolls 1, 2 for rolling a metal strip B, comprising back-up rolls 8, 9, 10, 11 which provide lateral support to their respectively allocated work rolls 1, 2 , with support force directed towards the work rolls 1, 2 being able to be applied to said back-up rolls by means of a force generation device, and comprising support rolls or intermediate rolls 3, 4 which are borne by a chock which can be slid into the roll stand W 1 , W 2 in the direction of the longitudinal axis of said chock 7 , and wherein said chock can be withdrawn from said roll stand, with each support roll or intermediate roll supporting an associated work roll 1, 2 in a direction which is essentially perpendicular to the direction of movement of the metal strip B. In such a roll stand, changing of the rolls can be carried out more quickly and easily in that the back-up rolls 8, 9, 10, 11 can be positioned from an idle position in which they are arranged outside the region where the chock 7 of the support roll or intermediate roll 3, 4 moves during slide-in or withdrawal, to an operating position in which they rest against the work roll 1, 2.
Patent AU-6191799-A (AU)
Title: Communication network
Inventor: MULLER THOMAS
IPC: H04L12/56
Filed: 1999-09-17
Abstract: A transmitter for transmitting an intermittent sequence of messages to maintain synchronization between the transmitter and a receiver. The transmitter includes control apparatus which provides messages for transmission, each message forms part of a sequence of messages and includes control information and timing information, and transmission apparatus which transmits each message. A receiver for synchronizing with a sequence of the transmitted messages. The receiver includes receiver and synchronization apparatus responsive, when enabled, to the control information in the message to indicate to the control apparatus reception of the message. The control apparatus controls power conservation by disabling the receiver and synchronization apparatus for a period of time dependent upon the timing information and enabling the receiver and synchronization apparatus to receive a following message in the sequence.
Patent AU-6332199-A (AU)
Title: New sustained release oral formulations
Inventor: KALB OSKAR
IPC: A61K9/22
Filed: 1999-10-01
Abstract: Pharmaceutical composition capable of releasing a therapeutically effective dose of active agent, e.g., rivastigamine, in a time-controlled manner.
Patent AU-6618798-A (AU)
Title: Wet-process technique for refining phosphoric acid
Inventor: POTENCSIK ISTVAN
IPC: C01B25/46
Filed: 1998-02-02
Abstract: A process for purification by multistage countercurrent extraction of wet-process phosphoric acid includes the steps of (a) preparing an aqueous phosphoric acid by decomposition of crude phosphates with sulfuric acid and prepurification thereof; (b) providing an organic solvent mixture consisting of one of (A) a water immiscible solvent and a fully water-miscible solvent or (B) a partially water-miscible solvent and a fully water-miscible solvent; (c) extracting water from the acid by contacting with the solvent mixture in a volumetric ratio of acid to solvent mixture of 1:1 to 1:10 at a temperature of 5 to 90° C.; (d) recovering the fully water-miscible solvent by distillation and washing; (e) recycling the fully water-miscible solvent to step (b) to provide a recycled solvent mixture; and (f) repeating steps (c), (d) and (e) with the recycled solvent mixture to provide a phosphoric acid having a preselected degree of purity.